Publications | Flatiron Health | Health equity

Browse every publication tagged Health equity

May 2026
Real-world post-progression outcomes following 1L ribociclib + aromatase inhibitor (AI) versus Al alone in African American and low socio-economic status patients with HR+/HER2- mBC in US
March 2026
Health disparities in acute myeloid leukemia patients undergoing treatment with tyrosine kinase inhibitor (TKI) therapy targeting FLT3, IDH1, or IDH2
December 2025
Racial/ethnic inequities in access to novel therapies and outcomes in triple negative breast cancer
- Health equity
- Breast cancer
November 2025
Mediators of racial and ethnic inequities in access to front-line therapies for chronic lymphocytic leukemia in the United States: A real-world evidence study
- Health equity
- Hematologic malignancies
July 2025
Fairness by design: End-to-end bias evaluation for LLM-generated data
May 2025
Assessment of racial/ethnic inequities in uptake of PSMA-PET scans among patients with metastatic prostate cancer in the United States
- Health equity
- Prostate Cancer
May 2025
Impact of social determinants of health on mortality in diffuse large B-cell lymphoma (DLBCL) using real-world data
- Health equity
- Hematologic malignancies
May 2025
Racial and ethnic differences in biomarker testing for targetable alterations among patients with HR+ HER2- metastatic breast cancer (mBC)
- Health equity
- Breast cancer
October 2024
Mediators of racial/ethnic inequities in clinical trial participation among patients with cancer, 2011-2023
- Health equity
- Clinical development